Lawrence P. Guiheen
CIK: 0001554353
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ADMA BIOLOGICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Mar 17, 2026ADMA
ADMA BIOLOGICS, INC.
Gift(G)Direct30K shares- - Mar 17, 2026ADMA
ADMA BIOLOGICS, INC.
Gift(G)Indirect30K shares- - Mar 13, 2026ADMA
ADMA BIOLOGICS, INC.
Exercise(M)Direct30K shares at avg. $3.66$110K - Feb 9, 2026ADMA
ADMA BIOLOGICS, INC.
Award(A)Direct10.7K shares- - Jun 9, 2025ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct20K shares at avg. $20.96$419K - May 22, 2025ADMA
ADMA BIOLOGICS, INC.
Exercise(M)Direct1.2K shares at avg. $5.96$7K - May 22, 2025ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct1.2K shares at avg. $20.12$25K - May 21, 2025ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct7.8K shares at avg. $20.32$158K - May 21, 2025ADMA
ADMA BIOLOGICS, INC.
Exercise(M)Direct7.8K shares at avg. $5.96$46K - Feb 19, 2025ADMA
ADMA BIOLOGICS, INC.
Award(A)Direct10.9K shares- - Sep 9, 2024ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct9K shares at avg. $18.47$166K - Sep 9, 2024ADMA
ADMA BIOLOGICS, INC.
Exercise(M)Direct9K shares at avg. $10.80$97K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 17, 2026 | ADMA ADMA BIOLOGICS, INC. | Gift(G) | 30,000 | - | $0 | Direct |
| Mar 17, 2026 | ADMA ADMA BIOLOGICS, INC. | Gift(G) | 30,000 | - | $0 | Indirect |
| Mar 13, 2026 | ADMA ADMA BIOLOGICS, INC. | Exercise(M) | 30,000 | $3.66 | $109,800 | Direct |
| Feb 9, 2026 | ADMA ADMA BIOLOGICS, INC. | Award(A) | 10,690 | - | $0 | Direct |
| Jun 9, 2025 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 20,000 | $20.96 | $419,200 | Direct |
| May 22, 2025 | ADMA ADMA BIOLOGICS, INC. | Exercise(M) | 1,221 | $5.96 | $7,277 | Direct |
| May 22, 2025 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 1,221 | $20.12 | $24,567 | Direct |
| May 21, 2025 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 7,779 | $20.32 | $158,069 | Direct |
| May 21, 2025 | ADMA ADMA BIOLOGICS, INC. | Exercise(M) | 7,779 | $5.96 | $46,363 | Direct |
| Feb 19, 2025 | ADMA ADMA BIOLOGICS, INC. | Award(A) | 10,889 | - | - | Direct |
| Sep 9, 2024 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 9,000 | $18.47 | $166,189 | Direct |
| Sep 9, 2024 | ADMA ADMA BIOLOGICS, INC. | Exercise(M) | 9,000 | $10.80 | $97,200 | Direct |
1-12 of 12 transactions
About Guiheen Lawrence P.
Guiheen Lawrence P. (SEC CIK 0001554353) files insider reports with the SEC as Director of ADMA BIOLOGICS, INC. (ADMA).
Signal8 holds 6 ownership filings by Guiheen Lawrence P., all Form 4s, filed between Sep 11, 2024 and Mar 17, 2026. Those filings report 12 transactions, from Sep 9, 2024 to Mar 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Guiheen Lawrence P.'s filings is in RAMSEY, NJ.
Recent filings by Guiheen Lawrence P.
- Mar 17, 2026: Gifts of ADMA shares (2 lines, Form 4, code G).
- Mar 13, 2026: Option exercise of ADMA shares (Form 4, code M).
- Feb 9, 2026: Grant or award of ADMA shares (Form 4, code A).
- Jun 9, 2025: Open-market sale of ADMA shares (Form 4, code S).
- May 22, 2025: Option exercise of ADMA shares (Form 4, code M).
Other insiders filing for ADMA BIOLOGICS, INC. (ADMA)
- Kestenberg-Messina Kaitlin M., COO and SVP, Compliance
- Kohler Terry, CFO and Treasurer
- Grossman Jerrold B, Director
- Grossman Adam S, President and CEO
- ELMS STEVE, Director
- Tade Brad L., CFO and Treasurer